News J. Molner

Equities

MOLNRIPO

EE3100109034

Market Closed - Nasdaq Tallinn Other stock markets 07:41:49 2024-06-03 am EDT			5-day change	1st Jan Change
13.1 ^EUR	-5.76%		-2.24%	-4.73%

Apr. 30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
Mar. 04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	Apr. 30	CI
J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	Mar. 04	CI
Certain Ordinary Shares of J. Molner AS are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	Nov. 06	CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US	23-09-06	CI
J. Molner AS has completed an IPO in the amount of Ã‡1.199998 million.	22-11-07	CI
J. Molner AS has filed an IPO in the amount of Ã‡1.199998 million.	22-10-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer